Genzyme - 2/36 - Xconomy

Entry	Author	Date	Location
Report: Fabry Patients Sue Genzyme and Mt. Sinai Medical School	Ryan McBride	03/11/11	Boston
Epizyme Nabs Eisai Deal, Termeer Could Make $221.2M From Genzyme Buyout, Gates Funds Nimbus, & More Boston-Area Life Sciences News	Erin Kutz	03/11/11	Boston
Targeted Genetics, Re-invented as AmpliPhi, Bets on Anti-Bacterials, Moves HQ to London	Luke Timmerman	03/09/11	Seattle
Kahoots Bought By RentJuice, Skyhook Enlists Sony, MassChallenge Adds $1M from MA, & More Boston-Area Deals News	Erin Kutz	03/09/11	Boston
RXi Sells Stock and Warrants, Cardiorobotics Raises $6.6M, ImmunoGen Dishes On New Drugs, & More Boston-Area Life Sciences News	Erin Kutz	03/04/11	Boston
With Sanofi Buyout of Genzyme, Rare Disease Execs Upbeat About Interest in Their Niche	Ryan McBride	03/03/11	Boston
Alder Steers Next Antibodies To Unusual Places: Treating Migraines and High Cholesterol	Luke Timmerman	03/02/11	Seattle
Genzyme Rival Fails to Get FDA Approval	Ryan McBride	02/25/11	Boston
Quanterix Partners With Novartis, Athenahealth and Microsoft Sync Up, Vertex Nails Clinical Trial, & More Boston-Area Life Sciences News	Erin Kutz	02/25/11	Boston
iAMscientist, Backed by George Whitesides, Tries to Help Firms and Institutes Find Top Talent	Gregory T. Huang	02/23/11	Boston
Constant Contact Buys Bantam Live, Forest Pays $1.2B for Clinical Data, Paydiant Scores $7.6M, & More Boston-Area Deals News	Erin Kutz	02/23/11	Boston
Biocom Follows the Money, Revamps Local Confab to Lure Big Pharma VIPs To San Diego	Luke Timmerman	02/22/11	San Diego
Sanofi Buys Genzyme for $20B, Aveo Inks Deal with Astellas, Hologix Nabs FDA Approval, & More Boston-Area Life Sciences News	Erin Kutz	02/18/11	Boston
How Sanofi Could Start Off on the Right Foot in Cambridge	Steve Dickman	02/07/11	Boston
Genocea Announces New CEO, Pfizer to Add Jobs In MA, Ocular Raises $14M, and More Boston-Area Life Sciences News	Erin Kutz	02/04/11	Boston
NanoString, Snapping Up Genomic Health Veteran, Seeks to Prove Economic Value of Cancer Diagnostic	Luke Timmerman	02/03/11	Seattle
EnerNOC Acquires M2M, H3 Launches With Eisai Funding, Genzyme Talks With Sanofi Advance, & More Boston-Area Deals News	Erin Kutz	02/02/11	Boston
Genzyme-Sanofi Deal Might Be Close, Report Says	Ryan McBride	02/01/11	Boston
Genzyme Lets Sanofi Conduct Due Diligence	Erin Kutz	01/31/11	Boston
Merck, Staring at a Biotech Future, Seeks to Get in the Game With New Protein Drugs, Biosimilars	Luke Timmerman	01/28/11	National
Clinical Data Stock Soars on FDA Approval, Amgen Buys BioVex, Stromedix Raises $2M, & More Boston-Area Life Sciences News	Erin Kutz	01/28/11	Boston
Myriant Gets $60M, BioVex Bought By Amgen, Raindance Wraps Up $37.5M, & More Boston-Area Deals News	Erin Kutz	01/26/11	Boston
Sanofi Extends Genzyme Offer	Ryan McBride	01/24/11	Boston
Report: Sanofi To Up Genzyme Bid	Erin Kutz	01/14/11	Boston
Biogen Idec’s New R&D Boss, Doug Williams, Spurns Corner Office for a Return to Big Science	Luke Timmerman	01/06/11	Boston
Rich Aldrich, Biotech Powerbroker, Breaks Silence on New $87M Longwood Founders Fund	Ryan McBride	01/06/11	Boston
Longwood Raises $85M First Fund	Ryan McBride	01/03/11	Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of 2010	Gregory T. Huang	12/27/10	Boston
Sanofi Taps Avila Therapeutics for Covalent Cancer Drugs in Potential $800M Deal	Ryan McBride	12/20/10	Boston
DARPA Backs Pulmatrix’s Lung Treatment, Adimab Scores More Pharma Partners, Semprus Secures $18M, & More Boston-Area Life Sciences News	Rebecca Zacks	12/17/10	Boston
Page 2 of 12	« previous page · next page »

Entry

Author

Date

Location

Report: Fabry Patients Sue Genzyme and Mt. Sinai Medical School

03/11/11

Epizyme Nabs Eisai Deal, Termeer Could Make $221.2M From Genzyme Buyout, Gates Funds Nimbus, & More Boston-Area Life Sciences News

Erin Kutz

03/11/11

Boston

Targeted Genetics, Re-invented as AmpliPhi, Bets on Anti-Bacterials, Moves HQ to London

Luke Timmerman